Skip to Content

Committed to Safety: As we resume services, we are taking all necessary precautions to keep you safe while we care for you. Limited visitation is now in place. Review all our visitor policies and precautions. Get more information on COVID-19.

Publications, Platform & Poster Presentations

Journal Article Publications

  • Evaluation of the Accuracy of Different Methods Used to Estimate Ideal Body Weight in the Pediatric Population J Pediatr Pharmacol Ther 2019;24(5):421-430 - Kenny Kang, Randy Absher, Elizabeth Farrington, Renee Ackley and Tsz- Yin So
  • A Review on the Use of Cystic Fibrosis Transmembrane Conductance Regulator Gene Modulators in Pediatric Patients. J Pediatr Health Care 2019; 33:356-364 - Michael Bitonti, Laura Fritts and Tsz-Yin So
  • The Use of Codeine and Tramadol in the Pediatric Population – What is the Verdict Now? J Pediatr Health Care 2019;33:117-123 - Megan Fortenberry, Justin Crowder and Tsz-Yin So
  • A Literature Review on the Use of Dornase Alfa in Pediatric Patients with Lower Respiratory Tract Illnesses other than Cystic Fibrosis. Arch Pediatr Neonatol 2018;1(1):26-35 - Radha Patel and Tsz-Yin So
  • Evaluation of the Efficacy of a Onetime Injectable Dexamethasone Administered Orally in the Pediatric Emergency Department for Asthma Exacerbation. J Pediatr Pharmacol Ther 2017;22(5):326-331 - McCallister A, So TY. 
  • Treatment of Pediatric Clostridium difficile Infection: A Review on Treatment Efficacy and Economic Value. Infect Drug Resist 2017;10:365-375 - D’Ostroph AR, So TY. 
  • Assessing Medication Adherence at a Student-Run Free Health Clinic.  Journal of Student Run Free Clinics. Vol 3 No 1. Sept 17, 2017. - Lam FW, Kaplan MC, Gazda NP, Shah MD, Toler JA, Scolaro, KL. 
  • Impact of Developing Adult Ketamine Order Panels for the Emergency Department. Hosp Pharm 2017;1-5 - Baird H, Rumbarger R. 
  • Real-world Experience with Oritavancin Therapy in Invasive Gram-Positive Infections. Infect Dis Ther 2017;6:277-289 - Stewart C, Turner M, Frens J, Snider C, Smith J.  
  • Elements of Success for Transitioning to the Role of Director of Pharmacy. Am J Health Syst Pharm 2017;74:557-561 - Granko RP, Thompson JM, Morton CS, Little JD. 
  • Comparison of Two Medication Therapy Management Practice Models on Return on Investment. J Pharm Pract 2017;30(3):282-285 - Gazda NP, Ferreri S. Berenbrok L. 
  • Strategy for Pharmacy Data Management. Am J Health Syst Pharm 2017;74:79-85 - Wolfe A, Hess L, La MK, Pappas AL, Moore R, Granko RP, Daniels, R. 
  • Current Clinical Trials on the Use of Ceftaroline in the Pediatric Population. Clin Drug Investig 2017; 37(7):625-634 - Corey A, So TY. 
  • Primary Immunization of Human Papillomavirus Vaccine in the Pediatric Population – What Is the Verdict Now? Clin Pediatr (Phila) 2017;56(7):605-615 - Jones AN, Barlett JW, Bates RA, So TY. 
  • The Use of Citrulline for Pediatric Pulmonary Hypertension. Res J Clin Pediatr 2017;1:1-6 - Yang S, So TY. 
  • Pharmacy Practice: Exploring the Relationship between SSRIs and Sodium Levels in an Older Adult Population. Inov Pharm. 2016;7(4): Article 14. - Anderson SL, Johnston N. 
  • Pharmacists’ Impact on Opportunistic Infection Prophylaxis in Patients with HIV/AIDS. J Hosp Infect 2016;94(4):389-392 - Schatz K, Guffey W, Maccia M, Templin M, Rector K. 
  • Medication Use Evaluation of Dronedarone in Comparison to Amiodarone. Inov Pharm. 2016;7(4): Article 18. - Corey A, Johnston N. 
  • Medication Reconciliation Limitations: Observation of the Medication Reconciliation Process in the Emergency Department by Two Immersion Pharmacy Students. Inov Pharm. 2016;7(4): Article 4. - Chong C, Haile A. 
  • Medication Adherence Survey: A First Year Pharmacy Immersion Students’ Perspective. Inov Pharm. 2016;7(3): Article 8. - Ortiz Lopez CF, Li M, Johnston N. 
  • Patient Medication Use: Interpreting the Results of a Patient Medication Safety Survey by Phase I Immersion Pharmacy Students. Inov Pharm. 2016;7(3): Article 4. - Li M, Ortiz Lopez CF, Johnston N, et al. 
  • Attention Deficit Hyperactive Disorder and Occurrence of Tic Disorders in Children and Adolescents-What is the Verdict Now? Curr Pediatr Rev. 2016;12(3):230-238 - Cooke T, So TY. 
  • Standardize Practice to Identify IV Errors. Pharmacy Purchasing and Products, May 2016, page 20 - Granko RP, McCallister A. 
  • Transitioning antimicrobials from intravenous to oral in pediatric acute uncomplicated osteomyelitis. World J Clin Pediatr 2016; 5(3): 244-250 - Batchelder N, So TY. 
  • Hypersensitivity Reaction to Insulin Glargine and Insulin Detemir in a Pediatric Patient: A Case Report. J Pediatric Pharmacol Ther. 2016;21(1):85-91 - Badik J, Chen J, Letvak K, So TY.  
  • Current Clinical Trials on the Use of Direct Oral Anticoagulants in the Pediatric Population. Cardio Ther 2016;5(1):19-41 - von Vajna E, Alam, R, So TY. 
  • The Use of Penicillin for the Prevention of Pneumococcal Infection in Pediatric Patients with Sickle Cell Disease. J Pediatr Sci 2015;7:e246 - Lawuyi B, Basham J, So TY. 
  • The Risk of Musculoskeletal Adverse Events with Fluuroquinolones in Children: What is the Verdict Now? Clin Pediatr 2016; 55(2):107-110 - Binz J, Adler C, So TY. 
  • Overview of Pharmacological Treatment Options for Pediatric Patients with Refractory Kawasaki Disease. J Pediatric Pharmacol Ther. 2015;20(3):163-177 - Saneeymehri S, Baker K, So TY. 
  • Promoting Pharmacy Business Success through the Implementation of a Departmental Operating Review Series. Am J Health Syst Pharm 2015; 72:610-613 - Granko RP, Lamm M. 

  • Assessing the Personal Performance And Professional Self-development Potential of a Pharmacy Management Practitioner. Am J Health Syst Pharm 2015; 72:149-157 - Granko RP, Wolfe A, Morton C,

Website & Magazine Articles